Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.85ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDDENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.2 (Zeta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
N.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.499ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
N.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.212ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.86ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.41.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GS.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JF.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JG.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBBENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GW.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.623ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.214.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.588ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.210ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.567ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.541ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.189ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.563ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.258ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.426ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.399ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used